Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs aimed at expanding the horizons of cytokine-based immunotherapy, especially for cancers where treatment options remain limited. Use the links below to learn more about our portfolio of cytokine-based immunotherapy candidates. Explore Our Pipeline We're https://financefeeds.com/dtx-exchange-sets-final-token-price-at-0-36-as-presale-concludes/